Cardiovascular effects of cyclooxygenase‐2 inhibitors: a mechanistic and clinical perspective

E-ISSN： 1365-2125|82|4|957-964

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.82, Iss.4, 2016-10, pp. : 957-964

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Nimesulide, a Selective Cyclooxygenase-2 Inhibitor, on Cardiovascular Alterations in Endotoxemia

Cardiology, Vol. 103, Iss. 2, 2005-02 ,pp. : 92-100

Karger

Access to resources Recommend Favorite

Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs

By Hermann Matthias Ruschitzka Frank

Annals of Medicine, Vol. 39, Iss. 1, 2007-01 ,pp. : 18-27

Informa Healthcare

Access to resources Recommend Favorite

Cyclooxygenase-2 inhibitors: promise or peril?

By Mengle-Gaw Laurel J. Schwartz Benjamin D.

Mediators of Inflammation, Vol. 11, Iss. 5, 2002-10 ,pp. : 275-286

Informa Healthcare

Access to resources Recommend Favorite

Biochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in Neoplasia

By Fosslien Egil

Critical Reviews in Clinical Laboratory Sciences, Vol. 37, Iss. 5, 2000-09 ,pp. : 431-502

Informa Healthcare

Access to resources Recommend Favorite

Glucagon‐like peptide 1 receptor agonists and cardiovascular risk in type 2 diabetes: a clinical perspective

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 4, 2015-04 ,pp. : 335-342

John Wiley & Sons Inc

Access to resources Recommend Favorite